Yahoo Web Search

Search results

    • Merck to acquire EyeBio in potential $3B deal

      NJBIZ· 5 days ago

      On Wednesday morning, Rahway-headquartered Merck announced it will acquire EyeBio in a deal that has a potential value of $3 billion. The agreement will bring EyeBio into Merck’s umbrella as ...

    • Merck to Acquire EyeBio

      Morningstar· 5 days ago

      Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eyebiotech Limited (EyeBio), a privately held ophthalmology-focused biotechnology company, today announced that the ...